What is Jupiter Bioscience Ltd. Quarterly Revenue?

Jupiter Bioscience Ltd. Quarterly Revenue Jupiter Bioscience Dec-2011 Quarterly Revenue is Rs 11 Cr which is growth of -81.9% YoY.

What is Jupiter Bioscience Ltd. Quarterly Net Profit?

Jupiter Bioscience Ltd. Quarterly Net Profit Jupiter Bioscience Dec-2011 Quarterly Net Profit is Rs -15 Cr which is growth of -234.3% YoY.

What is Jupiter Bioscience Ltd. Annual Revenue?

Jupiter Bioscience Ltd. Annual Revenue Jupiter Bioscience Annual Revenue is Rs 253 Cr which is growth of 37.6% YoY.

What is Jupiter Bioscience Ltd. Annual Net Profit?

Jupiter Bioscience Ltd. Annual Net Profit Jupiter Bioscience Annual Net Profit is Rs 33 Cr which is growth of 8.4% YoY.

What is Jupiter Bioscience Ltd. Total Shareholders Fund?

Jupiter Bioscience Ltd. Total Shareholders Fund Jupiter Bioscience Total Shareholders Fund is Rs 754 Cr which is growth of 132.6% YoY.

What is Jupiter Bioscience Ltd. Total Assets?

Jupiter Bioscience Ltd. Total Assets Jupiter Bioscience Total Assets is Rs 1,248 Cr which is growth of 58.1% YoY.

What is Jupiter Bioscience Ltd. Book Value Per Share?

Jupiter Bioscience Ltd. Book Value Per Share Jupiter Bioscience Book Value Per Share is 121 Rs which is growth of -39.9% YoY.

What is Jupiter Bioscience Ltd. ROE?

Jupiter Bioscience Ltd. ROE Jupiter Bioscience ROE is 4% which is growth of 5.1% YoY.

What is Jupiter Bioscience Ltd. Cash From Operating Activity?

Jupiter Bioscience Ltd. Cash From Operating Activity Jupiter Bioscience Cash From Operating Activity is Rs 89 Cr which is growth of 27.3% YoY.

What is Jupiter Bioscience Ltd. Net Cash Flow?

Jupiter Bioscience Ltd. Net Cash Flow Jupiter Bioscience Net Cash Flow is Rs -0 Cr which is growth of -116.0% YoY.

Jupiter Bioscience Ltd.

BSE: 524826

Portfolio

Alert

My Notes

Jupiter Bioscience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents

View Charts

Jupiter Bioscience quarterly results: revenue, profit, and P&L – 13 quarter history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

Nested row level

Base Level

Export

NEGATIVE
Quarterly Revenue Jupiter Bioscience Dec-2011 Quarterly Revenue is Rs 11 Cr which is growth of -81.9% YoY.
NEGATIVE
Quarterly Net Profit Jupiter Bioscience Dec-2011 Quarterly Net Profit is Rs -15 Cr which is growth of -234.3% YoY.

Jupiter Bioscience Ltd., Quarterly, standalone, All financials are in INR Cr and price data in INR
Indicator	Dec '11	Sep '11	Jun '11	Mar '11	Dec '10	Sep '10	Jun '10	Mar '10	Dec '09	Sep '09	Jun '09	Mar '09	Dec '08
TOTAL_SR_Q Total Rev. ⌄	11.5	33.5	43.8	79.3	63.4	59.3	51.4	58.4	49.2	42.9	33.5	47.8	35.7
SR_Q Operating Rev.	11.4	33.3	43.6	79.3	63.3	59.2	51.3	58.6	49.1	42.8	33.4	47.4	35.7
OI_Q Other Income	0	0.2	0.1	-0	0.1	0.1	0.1	-0.2	0.1	0.1	0.1	0.3
OEXPNS_Q Operating Exp.	8.6	15.4	20.8	57.2	31.5	29.6	25.1	26.1	25.3	22.1	14.9	26	18.1
OEXPNS_Q Operating Exp.	8.6	15.4	20.8	57.2	31.5	29.6	25.1	26.1	25.3	22.1	14.9	26	18.1
OP_Q Operating Profit	2.8	17.9	22.9	22.1	31.7	29.7	26.2	32.5	23.8	20.7	18.5	21.4	17.5
OPMPCT_Q Operating Profit Margin %	24.67%	53.68%	52.39%	27.93%	50.16%	50.09%	51.11%	55.45%	48.54%	48.39%	55.44%	45.08%	49.20%
DEP_Q Depr.	10.2	10.2	10.2	16.1	9.8	9.5	9.1	17.6	6.9	5.6	5.1	5.1	4
INT_Q Interest	7.5	7.3	8	2	8.6	7.8	7.1	5.1	6.9	5.9	5.3	5.2	5
PBT_Q Profit Before Tax	-14.9	0.5	4.8	4.1	13.4	12.5	10.1	9.6	10.1	9.3	8.3	11.4	8.5
TAX_Q Tax		0.1	1	-3.8	2.3	2.1	1.7	1	1.1	1.1	0.9	1.3	1
NP_Q Net Profit	-14.9	0.4	3.9	3.6	11.1	10.4	8.4	6.3	8.9	8.3	7.3	10.1	7.6
EPS_adj_Q EPS Adj. latest	-	-	-	-	-	-	-	-	-	-	-	-	-
NP_TTM Net profit TTM	-7	19	28.9	33.4	36.1	33.9	31.9	30.8	34.6	33.3	32.3	32	31.7
EPS_TTM Basic EPS TTM	-1.1	3	4.6	5.4	5.8	12.4	19.8	19.1	21.5	20.6	20.1	19.8	19.7

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Jupiter Bioscience competitor comparison and performance snapshot within industry

Jupiter Bioscience annual results: revenue, profit, P&L, and margins as of Mar 2011 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Annual Revenue Jupiter Bioscience Annual Revenue is Rs 253 Cr which is growth of 37.6% YoY.
POSITIVE
Annual Net Profit Jupiter Bioscience Annual Net Profit is Rs 33 Cr which is growth of 8.4% YoY.

Jupiter Bioscience Ltd., Annual, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	TTM	Mar '11	Mar '10	Mar '09	Mar '08	Mar '07	Mar '06	Mar '05	Mar '04
SR_A Total Rev. Ann. ⌄	24.6%	25.9%	167.9	253.3	184	145.3	131.1	104.1	80.2	71.1	65.9
TotalOperatingRevenues_A Operating Rev. Ann.	24.9%	25.9%	167.6	253.1	183.9	142.9	129.8	104	80	71	65.7
OI_A Other Income Ann.	-46.4%	0%	0.3	0.2	0.1	2.3	1.3	0.1	0.2	0.1	0.2
OEXPNS_A Operating Exp. Ann.	26.1%	26.1%	102	143.3	88.4	69.5	71.4	58.7	44.9	40.4	38.7
OEXPNS_A Operating Exp. Ann.	26.1%	26.1%	102	143.3	88.4	69.5	71.4	58.7	44.9	40.4	38.7
OP_A Operating Profit Ann.	23.4%	25.6%	65.7	109.8	95.6	73.4	58.4	45.3	35.1	30.6	27
OPMPCT_A OPM Ann. %	-0.9%	-0.2%		43.35%	51.94%	50.52%	44.57%	43.55%	43.80%	43.03%	41.00%
TotalExpenses_A Total Exp. Ann. ⌄	28.9%	29.6%		213.3	146.7	113.2	99.7	78.6	58.3	51.1	47.8
OtherExpenses_A Other Exp. Ann.	-0.5%	-	19.8	13.6	15.9	15.1	13.8	8	-4	-8	-8.6
EmployeeBenefitExpenses_A Employee Exp. Ann.	15.1%	23.8%	6	6.4	5	4.7	4.2	2.6	2.2	1.9	2.7
CostOfPowerPurchased_A Cost Of Power Purchased Ann.	-	-
CostOfFuel_A Cost Of Fuel Ann.	-	-
EBIDT_A EBITDA Ann.	22.6%	25.5%		109.9	95.6	75.7	59.7	45.5	35.3	30.7	27.2
EBIDTPCT_A EBITDA Ann. margin %	-1.6%	-0.3%		43.40%	51.98%	52.13%	45.53%	43.66%	44.00%	43.19%	41.23%
INT_A Interest Ann.	32.3%	43.4%	24.8	25.5	23.2	17.4	11	6.8	4.2	3.1	3.1
DEP_A Depr.	37%	37.1%	46.7	44.5	35.2	26.2	17.3	13.2	9.2	7.6	6.1
PBT_A PBT Ann.	8.3%	12.7%	-5.5	39.9	37.3	32.1	31.4	25.5	21.9	20	18.1
TAX_A Tax Ann.	0%	6.3%	-2.7	6.5	4.1	3.9	6.5	6.7	4.8	3.7	2.3
PAT_A PAT Before ExtraOrdinary Items Ann. ⌄	10.3%	14.3%		33.4	33.1	28.2	24.9	18.8	17.1	16.4	15.8
IncomeMinorityInterest_A Minority Interest Income Ann.	-	-		-	-	-	-	-	-	-	-
NP_A Net Profit Ann.	7.3%	14.3%	-7	33.4	30.8	28.2	27	18.8	17.1	14.2	15.2
NETPCT_A NPM Ann. %	-14.1%	-9.2%		13.20%	16.75%	19.72%	20.82%	18.09%	21.41%	19.94%	23.16%
EPS_adj_A EPS Adj. latest Ann.	-	-		-	-	-	-	-	-	-	-
Annual_Reports Annual Reports

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Rev. Ann.

1Y CHG

37.7%

2Y CAGR

32%

3Y CAGR

24.6%

5Y CAGR

25.9%

7Y CAGR

21.2%

Total Revenue Annual growth is higher than historical averages.

Net Profit Ann.

1Y CHG

8.4%

2Y CAGR

8.8%

3Y CAGR

7.3%

5Y CAGR

14.3%

7Y CAGR

11.9%

Net Profit Annual growth is stable compared to historical averages.

Operating Exp. Ann.

1Y CHG

62.1%

2Y CAGR

43.6%

3Y CAGR

26.1%

5Y CAGR

26.1%

7Y CAGR

20.6%

Operating Expenses Annual Cr growth is higher than historical averages.

Jupiter Bioscience balance sheet as of Mar 2011: assets, liabilities, reserves, and borrowings – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Total Shareholders Fund Jupiter Bioscience Total Shareholders Fund is Rs 754 Cr which is growth of 132.6% YoY.
POSITIVE
Total Assets Jupiter Bioscience Total Assets is Rs 1,248 Cr which is growth of 58.1% YoY.

Jupiter Bioscience Ltd., Balance Sheet, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '11	Mar '10	Mar '09	Mar '08	Mar '07	Mar '06	Mar '05	Mar '04
TotalShareHoldersFunds_A Total ShareHolders Funds Ann. ⌄	37.1%	46.1%	753.8	324	297	292.4	144.3	113.4	98.8	86.9
EQCAP_A Equity Share Capital Ann.	51.1%	47.6%	62.4	16.1	16.1	18.1	9.9	8.9	8.9	8.9
TotalShareCapital_A Total Share Capital Ann.	51.1%	47.6%	62.4	16.1	16.1	18.1	9.9	8.9	8.9	8.9
ReservesAndSurplus_A Reserves Plus Surplus Ann.	36.1%	45.9%	691.4	307.9	280.9	274.3	134.5	104.6	90	78.1
TotalReservesAndSurplus_A Total Reserves Plus Surplus Ann.	36.1%	45.9%	691.4	307.9	280.9	274.3	134.5	104.6	90	78.1
LiabilityMinorityInterest_A Minority Interest Liability Ann.	-	-	-	-	-	-	-	-	-	-
TotalNonCurrentLiabilities_A Total Non Current Liabilities Ann. ⌄	-47.2%	-23.4%	23.9	365.2	244.2	162.2	131.1	90.9	63.1	50.7
DeferredTaxLiabilities_A Deferred Tax Liabilities Ann.	53.6%	85.1%	23.9	14.5	10.4	6.6	0.1	1.1	1.7	1.1
OtherLongTermLiabilities_A Other LongTerm Liabilities Ann.	-	-
CL_A Total Current Liabilities Ann. ⌄	96.7%	96.6%	425.4	55.2	61.7	55.9	53	14.5	9.1	8
TradePayables_A Trade Payables Ann.	18.6%	20.1%		1	0.9	0.7	0.6	0.5	0.4	0.3
OtherCurrentLiabilities_A Other Current Liabilities Ann.	46.8%	28.1%	7.6	3.1	4.3	2.4	2	2.2	2.2	1.8
ShortTermProvisions_A ST Provisions Ann.	5.1%	12.4%	21	7.7	13.4	18.1	16.1	11.7	6.6	5.8
TL_A Total Capital Plus Liabilities Ann.	33.9%	41.1%	1,248	789.4	632.1	519.8	350.5	222.9	171.1	145.6
FixedAssets_A Fixed Assets Ann. ⌄	25.9%	42.1%	542.2	458.2	350.6	271.9	163.6	93.5	77.7	67.1
TangibleAssets_A Tangible Assets Ann.	24.3%	40.4%	368.7	319.3	256.2	192	108.4	67.6	63.3	53.4
IntangibleAssets_A Intangible Assets Ann.	-	-
CapitalWorkInProgress_A Capital Work In Progress Ann.	29.5%	46.3%	173.5	138.9	94.4	79.9	55.2	25.9	14.4	13.8
TotalNonCurrentAssets_A Total Non Current Assets Ann. ⌄	35.5%	42.5%	1,045.2	650.9	517	420.2	275	177.7	135.5	112.2
NonCurrentInvestments_A Non Current Investments Ann.	58.6%	55.8%	503	177.8	147.9	126.2	85.6	54.8	32.5	27.9
DeferredTaxAssets_A Deferred Tax Assets Ann.	-	-
LongTermLoansAndAdvances_A LT Loans Plus Advances Ann.	-	-
OtherNonCurrentAssets_A Other Non Current Assets Ann.	-16.7%	-10%		14.9	18.5	22.2	25.8	29.4	25.3	17.2
CA_A Total Current Assets Ann. ⌄	26.7%	35%	202.8	138.5	115.1	99.6	75.5	45.2	35.6	33.4
CurrentInvestments_A Current Investments Ann.	-	-
TradeReceivables_A Trade Receivables Ann.	24.9%	30.2%	63.9	43.6	38.2	32.8	25.4	17.1	12.5	8.8
CashAndCashEquivalents_A Cash Plus Cash Equivalents Ann.	28.7%	23.8%	3.2	3.6	0.8	1.5	2.3	1.1	0.8	5.6
ShortTermLoansAndAdvances_A ST Loans Plus Advances Ann.	20.6%	53.6%	39.3	32	26.5	22.4	14.1	4.6	1.7	1.8
OtherCurrentAssets_A Other Current Assets Ann.	-	-	29
TA_A Total Assets Ann.	33.9%	41.1%	1,248	789.4	632.1	519.8	350.5	222.9	171.1	145.6
ContingentLiabilities_A Contingent Liabilities plus Commitments Ann.	-	-			7
BonusEquityShareCapital_A Bonus Equity Share Capital Ann.	-	-
NonCurrentInvestmentsUnquotedBookValue_A Non Current Investments Unquoted Book Value Ann.	58.9%	56.3%	502	176.8	146.9	125.2	84.6	53.8	30.5	25.9
CurrentInvestmentsUnquotedBookValue_A Current Investments Unquoted Book Value Ann.	-	-

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Total Assets Ann.

1Y CHG

58.1%

2Y CAGR

40.5%

3Y CAGR

33.9%

5Y CAGR

41.1%

7Y CAGR

35.9%

Total Assets Annual growth is higher than historical averages.

Total Current Liabilities Ann.

1Y CHG

670.7%

2Y CAGR

162.6%

3Y CAGR

96.7%

5Y CAGR

96.6%

7Y CAGR

76.4%

Total Current Liabilities Annual Cr growth is higher than historical averages.

Total ShareHolders Funds Ann.

1Y CHG

132.7%

2Y CAGR

59.3%

3Y CAGR

37.1%

5Y CAGR

46.1%

7Y CAGR

36.2%

Total ShareHolders Funds Annual growth is higher than historical averages.

Jupiter Bioscience ROE, ROCE, book value, and debt-to-equity ratio as of Mar 2011 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

NEGATIVE
Book Value Per Share Jupiter Bioscience Book Value Per Share is 121 Rs which is growth of -39.9% YoY.
POSITIVE
ROE Jupiter Bioscience ROE is 4% which is growth of 5.1% YoY.

Jupiter Bioscience Ltd., Ratios, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '11	Mar '10	Mar '09	Mar '08	Mar '07	Mar '06	Mar '05	Mar '04
BVSH_A BVSH Ann.	-9.2%	-1.2%	120.7	200.9	184.1	161.3	146.3	128	111.5	98.1
ROA_A RoA Ann. %	-19.9%	-19%	2.67%	3.90%	4.45%	5.20%	5.36%	7.68%	8.27%	10.45%
ROE_A ROE Ann. %	-21.7%	-21.7%	4.43%	9.51%	9.49%	9.24%	13.03%	15.10%	14.32%	17.51%
ROCE_A ROCE Ann. %	-11.3%	-13.2%	4.06%	4.19%	4.94%	5.82%	6.32%	8.22%	8.74%	11.06%
ProfitabilityHeader Profitability Ratio ⌄
PBDITMargin_A EBITDA Ann. Margin %	-1.9%	-0.3%	43.42%	51.99%	52.97%	45.96%	43.70%	44.08%	43.25%	41.32%
PBITMargin_A EBIT Ann. Margin %	-7.5%	-4.5%	25.85%	32.85%	34.62%	32.61%	31.04%	32.59%	32.60%	32.10%
PBTMargin_A PBT Ann. Margin %	-13.2%	-10.4%	15.78%	20.26%	22.44%	24.16%	24.49%	27.39%	28.18%	27.46%
NETPCT_A NPM Ann. %	-14.1%	-9.2%	13.20%	16.75%	19.72%	20.82%	18.09%	21.41%	19.94%	23.16%
ASETTO_A Asset Turnover Ann. %	-6.7%	-10.8%	20.3	23.3	22.6	25	29.7	35.9	41.5	45.1
LiquidityHeader Liquidity Ratio ⌄
CRATIO_A Current Ratio Ann.	-34.8%	-30.6%	0.5	2.5	1.9	1.8	1.4	3.1	3.9	4.2
QuickRatio_A Quick Ratio Ann.	-33.1%	-28.5%	0.3	1.4	1.1	1	0.8	1.6	1.6	2
DividendPayoutNP_A Dividend Payout to NP Ann.	-	-	-	-	-	-	-	-	-	-
EarningRetention_A Earning Retention Ann. %	-2.1%	-1.4%	81.32%	89.54%	88.56%	86.59%	88.21%	87.08%	85.92%	88.36%
CashEarningRetention_A Cash Earning Retention Ann. %	0%	0%	92.35%	95.37%	94.45%	92.45%	93.77%	92.43%	91.57%	92.02%
CashEarningRetention_A Cash Earning Retention Ann. %	0%	0%	92.35%	95.37%	94.45%	92.45%	93.77%	92.43%	91.57%	92.02%
ValuationHeader Valuation Ratio ⌄
EnterpriseValue_A EnterpriseValue Ann.	4.8%	21.2%	517.7	525	336.8	449.7	305.3	198.2	161.5	144.8
EVPerNetSales_A EV Per Net Sales Ann.	-15.7%	-3.4%	2.1	2.9	2.4	3.5	2.9	2.5	2.3	2.2
PBV_A Price To Book Value Adjusted	-	-	-	-	-	-	-	-	-	-
EVPerEBITDA_A EV Per EBITDA Ann.	-14.4%	-3.4%	4.7	5.5	4.5	7.5	6.7	5.6	5.3	5.3
MarketCapPerSales_A Market Cap Per Sales Ann.	-37%	-18.6%	0.5	0.7	0.4	2	1.4	1.4	1.4	1.5
RetentionRatios_A Retention Ratio Ann. %	-2.1%	-1.4%	81.31%	89.53%	88.55%	86.58%	88.20%	87.07%	85.91%	88.35%
EYield_A Earnings Yield Ann.	44.2%	8.4%	0.3	0.2	0.5	0.1	0.1	0.2	0.1	0.2
DEBT_CE_A Total Debt to Total Equity Ann.	-10.6%	-9%	0.5	1.2	0.9	0.7	1.1	0.8	0.6	0.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

ROE Ann. %

1Y CHG

-53.4%

2Y CAGR

-31.7%

3Y CAGR

-21.7%

5Y CAGR

-21.7%

7Y CAGR

-17.8%

ROE Annual % is falling faster than historical averages.

RoA Ann. %

1Y CHG

-31.5%

2Y CAGR

-22.5%

3Y CAGR

-19.9%

5Y CAGR

-19%

7Y CAGR

-17.7%

RoA Annual % is falling faster than historical averages.

Current Ratio Ann.

1Y CHG

-80%

2Y CAGR

-48.7%

3Y CAGR

-34.8%

5Y CAGR

-30.6%

7Y CAGR

-26.2%

Current Ratio Annual is falling faster than historical averages.

Jupiter Bioscience cash flow: net, operating, investing, and financing flows as of Mar 2011 – 11 year history

Nested row level

Base Level

Reporting Type

Standalone

Cell Data

Actual

Table Settings

YoY & New to Old

CAGR Columns

Select...

Nested row level

Base Level

Export

POSITIVE
Cash From Operating Activity Jupiter Bioscience Cash From Operating Activity is Rs 89 Cr which is growth of 27.3% YoY.
NEGATIVE
Net Cash Flow Jupiter Bioscience Net Cash Flow is Rs -0 Cr which is growth of -116.0% YoY.

Jupiter Bioscience Ltd., Cash Flow, standalone, All financials are in INR Cr and price data in INR
Indicator	CAGR 3 Yrs	CAGR 5 Yrs	Mar '11	Mar '10	Mar '09	Mar '08	Mar '07	Mar '06	Mar '05	Mar '04
CFO_A Cash from Operating Act. Ann. ⌄	27.6%	25.8%	88.7	69.7	58.4	42.7	15.6	28.2	21.9	25.9
PBT_A PBT Ann.	8.3%	12.7%	39.9	37.3	32.1	31.4	25.5	21.9	20	18.1
INT_A Interest Ann.	32.3%	43.4%	25.5	23.2	17.4	11	6.8	4.2	3.1	3.1
TAX_A Tax Ann.	0%	6.3%	6.5	4.1	3.9	6.5	6.7	4.8	3.7	2.3
CFI_A Cash from Investing Act. Ann.	41.9%	54.1%	471.3	-172.6	-124.3	165.1	114.1	54.2	32.6	35.1
CFA_A Cash from Financing Act. Ann.	-	-	-560.5	105.8	65.2	121.7	99.6	26.3	5.9	14.2
NCF_A Net Cash Flow Ann. ⌄	-	-	-0.5	2.8	-0.7	329.4	229.3	108.7	60.4	75.2
CashAndCashEquivalentBeginOfYear_A Cash Plus Cash Eqv. Begin Of Year Ann.	16.1%	35.1%	3.6	0.8	1.5	2.3	1.1	0.8	5.6	0.7
CashAndCashEquivalentEndOfYear_A Cash Plus Cash Eqv. End Of Year Ann.	28.7%	23.8%	3.2	3.6	0.8	1.5	2.3	1.1	0.8	5.6

*All financials are in INR Cr and price data in INR

Add metric to table

Search...

Cash from Operating Act. Ann.

1Y CHG

27.3%

2Y CAGR

23.2%

3Y CAGR

27.6%

5Y CAGR

25.8%

7Y CAGR

19.2%

Cash from Operating Activity Annual growth is stable compared to historical averages.

Cash from Investing Act. Ann.

3Y CAGR

41.9%

5Y CAGR

54.1%

7Y CAGR

44.9%

Cash from Investing Activity Annual growth is higher than historical averages.

Jupiter Bioscience investor presentations, annual reports, credit ratings, and earnings calls with AI summary, video, and audio access

Quarterly
Competitors/Peers
Annual
Balance Sheet
Ratios
Cash Flow
Documents

Jupiter Bioscience quarterly and annual financials: results, revenue, profit, P&L, balance sheet, cash flow, financial ratios, revenue mix, peer comparison, and financial documents